The approach of World Health Organization to articulate the role and assure impact of vaccines against antimicrobial resistance
Open Access
- 24 November 2022
- journal article
- research article
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 18 (6) , 2145069
Abstract
Antimicrobial resistance (AMR) is a growing global problem and there were an estimated 4.95 million deaths associated with bacterial AMR worldwide in 2019. Vaccines can impact AMR by preventing infections and reducing the need for antibiotics which will inadvertently slow the emergence of AMR. Effective infection prevention and control (IPC) has been identified as the cornerstone action to combat AMR by the World Health Assembly and the Global Action plan on AMR. Similarly, the Immunization Agenda 2030 highlights vaccines as critical tools to combat AMR. This article summarizes the strategy of the World Health Organization to understand, articulate and communicate the important role of vaccines in countering AMR. The work is organized around developing a strategy, understanding the pipeline of vaccines in development, articulating the value of vaccines against AMR, and assuring sustainable impact of vaccines at a country level to combat AMR.Keywords
Funding Information
- Bill and Melinda Gates Foundation (INV-005318)
This publication has 16 references indexed in Scilit:
- Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling studyThe Lancet Infectious Diseases, 2019
- Antimicrobial resistance and the role of vaccinesProceedings of the National Academy of Sciences, 2018
- Impact of existing vaccines in reducing antibiotic resistance: Primary and secondary effectsProceedings of the National Academy of Sciences, 2018
- Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosisThe Lancet Infectious Diseases, 2018
- Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative actionPLOS Medicine, 2017
- Drug-Resistant Infections2017
- Will 10 Million People Die a Year due to Antimicrobial Resistance by 2050?PLOS Medicine, 2016
- A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistanceBMC Infectious Diseases, 2014
- Clinical and microbiological characteristics of tigecycline non-susceptible Klebsiella pneumoniaebacteremia in TaiwanBMC Infectious Diseases, 2014
- A Trial of a 9-Valent Pneumococcal Conjugate Vaccine in Children with and Those without HIV InfectionNew England Journal of Medicine, 2003